MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
14.12
+0.02 (0.14%)
At close: Jul 31, 2026, 4:00 PM EDT
14.12
0.00 (0.00%)
After-hours: Jul 31, 2026, 7:34 PM EDT
MediWound Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, MediWound stock has a consensus rating of "Strong Buy" and an average price target of $30.17. The average 1-year stock price forecast is 113.67% higher than the current stock price, while the lowest is $22 (+55.81%) and the highest is $36 (+154.96%).
Price Target: $30.17 (+113.67%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 2, 2026.
Analyst Ratings
The average analyst rating for MediWound stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $30 | Buy | Maintains | $30 | +112.46% | Jun 2, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +55.81% | May 28, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $34 → $32 | Buy | Maintains | $34 → $32 | +126.63% | May 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $14 → $36 | Buy | Reiterates | $14 → $36 | +154.96% | May 28, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $25 | Buy | Reiterates | $25 | +77.05% | May 27, 2026 |
Financial Forecast
Revenue This Year
24.13M
from 16.96M
Increased by 42.26%
Revenue Next Year
32.87M
from 24.13M
Increased by 36.26%
EPS This Year
-2.39
from -2.10
EPS Next Year
-2.22
from -2.39
EPS and Forward PE are based on non-GAAP adjusted numbers.